Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 16 studies | 49% ± 20% | |
| fibroblast | 14 studies | 26% ± 9% | |
| pericyte | 12 studies | 24% ± 6% | |
| GABAergic neuron | 10 studies | 49% ± 22% | |
| astrocyte | 10 studies | 26% ± 13% | |
| glutamatergic neuron | 9 studies | 37% ± 19% | |
| microglial cell | 8 studies | 35% ± 17% | |
| interneuron | 7 studies | 49% ± 22% | |
| endothelial cell | 6 studies | 31% ± 14% | |
| macrophage | 6 studies | 36% ± 20% | |
| retinal ganglion cell | 5 studies | 29% ± 11% | |
| connective tissue cell | 5 studies | 31% ± 10% | |
| cardiac muscle cell | 5 studies | 32% ± 9% | |
| granule cell | 4 studies | 30% ± 5% | |
| neuron | 4 studies | 41% ± 17% | |
| amacrine cell | 4 studies | 19% ± 4% | |
| endothelial cell of lymphatic vessel | 4 studies | 19% ± 4% | |
| smooth muscle cell | 4 studies | 23% ± 7% | |
| abnormal cell | 3 studies | 23% ± 5% | |
| GABAergic interneuron | 3 studies | 39% ± 6% | |
| progenitor cell | 3 studies | 27% ± 3% | |
| hepatocyte | 3 studies | 33% ± 17% | |
| neural progenitor cell | 3 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 1660.43 | 2626 / 2642 | 100% | 64.28 | 703 / 705 |
| prostate | 99% | 980.18 | 243 / 245 | 96% | 19.51 | 484 / 502 |
| thymus | 100% | 1142.72 | 653 / 653 | 91% | 16.31 | 550 / 605 |
| breast | 100% | 976.02 | 458 / 459 | 88% | 20.13 | 987 / 1118 |
| kidney | 99% | 908.03 | 88 / 89 | 85% | 14.08 | 762 / 901 |
| ovary | 100% | 885.92 | 180 / 180 | 69% | 8.15 | 296 / 430 |
| liver | 96% | 495.97 | 218 / 226 | 51% | 4.68 | 209 / 406 |
| uterus | 99% | 1225.96 | 169 / 170 | 26% | 6.12 | 121 / 459 |
| lung | 99% | 657.16 | 572 / 578 | 25% | 2.26 | 294 / 1155 |
| stomach | 100% | 673.75 | 359 / 359 | 15% | 1.48 | 42 / 286 |
| bladder | 100% | 1119.48 | 21 / 21 | 13% | 1.08 | 67 / 504 |
| skin | 89% | 654.38 | 1604 / 1809 | 22% | 2.19 | 105 / 472 |
| spleen | 100% | 2768.67 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 1127.10 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 910.71 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| heart | 100% | 1503.55 | 857 / 861 | 0% | 0 | 0 / 0 |
| muscle | 99% | 1080.71 | 796 / 803 | 0% | 0 | 0 / 0 |
| intestine | 81% | 807.34 | 778 / 966 | 9% | 0.72 | 49 / 527 |
| esophagus | 76% | 674.36 | 1092 / 1445 | 13% | 1.10 | 24 / 183 |
| pancreas | 24% | 66.34 | 79 / 328 | 57% | 4.57 | 102 / 178 |
| eye | 0% | 0 | 0 / 0 | 73% | 6.04 | 58 / 80 |
| adrenal gland | 37% | 112.66 | 96 / 258 | 18% | 1.76 | 41 / 230 |
| peripheral blood | 23% | 77.52 | 211 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 22% | 2.13 | 10 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.17 | 1 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0005813 | Cellular component | centrosome |
| GO_0005829 | Cellular component | cytosol |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005515 | Molecular function | protein binding |
| Gene name | FAM110B |
| Protein name | Protein FAM110B |
| Synonyms | C8orf72 |
| Description | FUNCTION: May be involved in tumor progression. |
| Accessions | ENST00000361488.7 Q8TC76 ENST00000519262.6 |